Evidence map›Paper›PMID 39200039›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Epidemiology and Impact of Anti-Pneumococcal Vaccination and COVID-19 on Resistance of

Alessandro Bondi, Emanuele Koumantakis, Antonio Curtoni, Anna Maria Barbui, Marco Peradotto, Daniela Lombardi, Roberto Casale, Silvia Alizzi, Elisa Zanotto, Lorena Charrier and 2 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Journal of preventive medicine and hygiene · 2026
    Article
  4. Serotype distribution and antimicrobial resistance ofJournal of medical microbiology · 2025
    Article
  5. Clinical microbiology reviews · 2025
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alessandro BondiMicrobiology and Virology Unit, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy.ORCID 0000-0002-1979-3229
Emanuele KoumantakisDepartment of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-6994-8375
Antonio CurtoniMicrobiology and Virology Unit, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy.ORCID 0000-0001-8101-4196
Anna Maria BarbuiMicrobiology and Virology Unit, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy.
Marco PeradottoMicrobiology and Virology Unit, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy.ORCID 0000-0001-6236-1010
Daniela LombardiRegional Epidemiology Reference Service for the Surveillance, Prevention and Control of Infectious Disease (SeREMI), 15121 Alessandria, Italy.
Roberto CasaleDepartment of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-7708-5303
Silvia AlizziMicrobiology and Virology Unit, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy.
Elisa ZanottoMicrobiology and Virology Unit, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy.
Lorena CharrierDepartment of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-1300-4508
Rossana CavalloMicrobiology and Virology Unit, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy.
Cristina CostaMicrobiology and Virology Unit, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy.ORCID 0000-0002-6549-4553

Funding

hin the MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT). Project no. PE00000007, INF-ACT
6 · The paper itself

Abstract

backgroundThe international surveillance of antimicrobial resistance (AMR) reports

methodsWe collected all strains of

resultsWe collected

conclusionsIn the Piedmont region, subsequently to the introduction of anti-pneumococcal vaccination, a significant increase in the risk of penicillin G-resistant invasive pneumococcal disease among infants and old population was reported. No significant impact was found for the SARS-CoV2 outbreak.

Indexed as

antimicrobial resistanceanti-pneumococcal vaccinationS. pneumoniae

Identifiers

PMID39200039
PMCPMC11350834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.